Discovery of dermorphin-based affinity labels with subnanomolar affinity for mu opioid receptors

J Med Chem. 2009 Dec 10;52(23):7372-5. doi: 10.1021/jm9007592.

Abstract

A series of potent electrophilic affinity labels (IC(50) = 0.1-5 nM) containing either a bromoacetamide or isothiocyanate based on the mu opioid receptor (MOR) selective peptide dermorphin were prepared. All four analogues exhibited wash resistant inhibition of [(3)H]DAMGO binding at subnanomolar to nanomolar concentrations, suggesting that these analogues bind covalently to MOR. To our knowledge, these peptides are the highest affinity peptide-based affinity labels for MOR reported to date.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Affinity Labels / chemical synthesis
  • Affinity Labels / chemistry*
  • Affinity Labels / metabolism*
  • Amino Acid Sequence
  • Animals
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Dose-Response Relationship, Drug
  • Drug Discovery
  • Opioid Peptides / chemical synthesis
  • Opioid Peptides / chemistry*
  • Opioid Peptides / metabolism*
  • Receptors, Opioid, mu / metabolism*

Substances

  • Affinity Labels
  • Opioid Peptides
  • Receptors, Opioid, mu
  • dermorphin